Clinical Trial Update: Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and immunogenicity of a human hookworm vaccine candidate with different doses of a novel adjuvant; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hookworm Disease
• Hookworm Infection

Snippet

Sponsor: Baylor College of Medicine | Conditions: Hookworm Infection, Hookworm Disease | Phase 1 | Status: COMPLETED | Results posted: 2017-04-20